Institute for Data Science in Oncology

 

At MD Anderson, we're unlocking the power of information to transform how we understand and treat cancer.

A new era in cancer care

The Institute for Data Science in Oncology, led by David Jaffray, Ph.D., and Caroline Chung, M.D., is transforming how we understand and treat cancer care.

 

Cancer is among the most complex diseases. Every patient’s treatment is shaped by biology, environment and treatment history. At the nation’s No. 1 hospital for cancer care, we are leading a bold approach through the Institute for Data Science in Oncology. Launched in November 2023, the institute harnesses artificial intelligence, big data and team science to improve outcomes for every patient. 

David Jaffray, Ph.D. Department of Radiation Physics, Division of Radiation Oncology; and Caroline Chung, M.D. Department of CNS - Rad Onc Clinical, Division of Radiation Oncology
LEARN MORE ABOUT THE INSTITUTE

Why data science matters

Each patient generates millions of data points. We bring these metrics together–in real time–to uncover hidden patterns, predict responses and personalize treatment.

Annual Report - Heiko Enderling, professor with IDSO at TMC3 co-lead interested in mathematical and computational models of cancer dynamics, with focus on quantitative personalized medicine, radiation therapy and immunotherapy on Friday, Nov. 15, 2024.

Stretegic Focus Areas

Enhances diagnosis and treatment precision 

Integrates imaging and pathology to deliver faster, more accurate diagnoses and personalized treatment plans.

 

Discovers new therapies at the cellular level 

Uses single-cell analytics and machine learning to decode how cancer begins and evolves–unlocking new drug targets.

 

Accelerates personalized medicine with AI 

Combines clinical data, imaging and advanced modeling to create adaptive treatment strategies and new therapies.

 

Improves public health through data-informed models 

Guides smarter population health strategies that reduce disparities, improve access and expand care globally.

 

Advances automation in cancer care 

Develops systems to increase safety, quality and access–from cybersecurity to patient scheduling.

Dr-David-Jaffray-consulting-data-science-lab
“This is our future. And IDSO is paving the way.”

Monika Bickert learned firsthand how difficult facing cancer could be when her late husband, Philip Guentert, was diagnosed with stage IV kidney cancer in 2012. Now, she’s using her background in tech and involvement with MD Anderson’s Institute for Data Science in Oncology (IDSO) to help MD Anderson offer more personalized care.

READ MONIKA'S STORY
Portrait of Monika Bickert, caregiver and board of visitors member. For use in print and digital

Impact Through Philanthropy That is Only Possible Here

 

With a fundraising goal of $150 million by 2028, the Institute for Data Science in Oncology is the largest investment in oncology data science in history. Your support expedites breakthroughs, recruits top talent and builds the infrastructure needed to make discoveries possible. Every gift brings us closer to a future where cancer care is smarter, faster and more personalized.

GIVE NOW

Guided by World Leaders in Oncology and Data Science

David Jaffray, Ph.D.

Chief Technology and Digital Officer

Senior Vice President

Meet Dr. Jaffray
David Jaffray, Signature Priority Leaders

Caroline Chung, M.D.

Vice President, Chief Data and Analytics Officer

Meet Dr. Chung
Caroline Chung, M.D.

Your support of the Institute for Data Science in Oncology’s collaborative, interdisciplinary research will help us to improve outcomes for every patient.

GIVE TO THE INSTITUTE FOR DATA SCIENCE IN ONCOLOGY